CoChat

Establishment of a Radiogenomics Consortium

Open access
West, Catharine, Rosenstein, Barry S. · 2010 · International Journal of Radiation Oncology*Biology*Physics
Cited by 139

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

A Radiogenomics Consortium was established in Manchester, United Kingdom November 17–18th 2009 in conjunction with the 15th LH Gray Workshop with investigators from throughout the world participating in the conference. The unifying interest of these researchers is the identification of genetic variants, primarily single nucleotide polymorphisms (SNPs), associated with the development of normal tissue toxicities resulting from radiation therapy. There are two overall goals for this field of research. The first is to develop an assay capable of predicting which cancer patients are most likely to develop radiation injuries resulting from treatment with a standard radiotherapy protocol. The second aim is to obtain information to assist with the elucidation of the molecular pathways responsible for radiation-induced normal tissue toxicities through identification of genes possessing SNPs associated with the development of radiation-induced adverse effects. The workshop included radiation biologists, radiation oncologists, epidemiologists and geneticists. As this effort continues, it is anticipated that individuals with expertise in radiation physics, statistics and bioinformatics will also play a critical role in the consortium. The group was brought together by a long standing interest to understand the variability in the susceptibility of cancer patients for the development of adverse effects following radiation therapy. It has been known for many years that patients vary in their sensitivity to radiation and that genetics plays an important role influencing this variation. In the 1990s, radiation biologists examined different endpoints to serve as the basis for an assay to predict radiosensitivity, but with no consistent finding emerging for any of the assays [1]. Towards the end of that decade, interest increasingly focused upon investigating genetic variation. Common SNPs form a major, easily assayable source of genetic variability between individuals. A SNP begins as a single base change (point mutation) in an individual, which if not deleterious, may become prevalent in a population. A base change observed in at least 1% of a population is termed a SNP, with less prevalent alternations usually referred to as ‘‘rare variants”. It should also be noted that copy number variants, which are also being examined in ongoing studies, represent an important source of genetic variation, but were not the focus of this meeting. Several small studies have suggested that possession of particular alleles of SNPs in relevant candidate genes may be associated with an increased risk of developing radiation toxicity [1,2]. However, as occurred for the previous era of cell based predictive assays, contradictory reports are emerging. It is clearly important

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2009.12.017

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 139

Metadata

Authors
West, C., & Rosenstein, B. S.
Venue
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Published
2010-04
Volume
76
Issue
5
Pages
1295-1296
ISSN
0360-3016 (ISSN-L)
OpenAlex
W2079722579
Cited by
139
References
1
FWCI
9.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.